MLB: Orioles minor league P Luis Ortiz dies of cancer at 20

Date:

Share post:


Baltimore Orioles minor league pitcher Luis Ortiz died Saturday from cancer at the age of 20.

The team confirmed the Dominican prospect’s passing on Sunday morning.

“Our hearts are heavy today as we mourn the passing of minor league pitcher Luis Andres Ortiz Soriano. We will miss his passion and love for the game of baseball, and we extend our deepest condolences to his family,” the Orioles said.

“Luis was an inspiration to all who knew him, especially as he courageously battled cancer. We hope that the cherished and treasured memories of Luis will be a comfort for his family and friends during this devastating time.”

Ortiz was a member of Baltimore’s 2019 international signing class.

The 6-foot-3 left-hander pitched in seven games in the Florida Complex League in 2021 but did not appear in any games in 2022.

“I want to start off by giving my condolences to Luis Ortiz and his family,” Orioles manager Brandon Hyde said to begin his media session on Sunday. “Sad news last night. From all of us here, our major league staff and players, we just want to give our condolences to the Ortiz family.”

–Field Level Media

spot_img

Related articles

MLB: Yankees acquire 3B Ryan McMahon from Rockies

The New York Yankees acquired third baseman Ryan McMahon from the Colorado Rockies in exchange for two minor...

MLB: Mets acquire LHP Gregory Soto from Orioles

The New York Mets bolstered their bullpen on Friday by acquiring left-handed reliever Gregory Soto from the Baltimore...

MLB: D-backs recall 1B Tristin English, option LHP Brandyn Garcia

The Arizona Diamondbacks recalled first baseman Tristin English from Triple-A Reno and optioned left-hander Brandyn Garcia to Triple-A. English,...

MLB: Braves reinstate 3B Austin Riley from injured list

The Atlanta Braves reinstated third baseman Austin Riley from the 10-day injured list on Friday. The two-time All-Star landed...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.